Accelerator mass spectrometry (AMS) is an ultrasensitive measure for tracing i4C labeled molecules in vivo or detecting the biomarker for assessment of carcinogenesis. Basic principles, wide applications and new progresses of bio-14C-AMS have been presented. It is a state-of-the-art tool for measuring the adduction of biological molecules with xenobiotics, including carcinogens, drugs, agrochemicals, nicotine etc.. We have studied the genotoxicity and proteins adduction of smoking specific nicotine and its nitrosamine derivative NNK since 1994. The successful applications have proven the effectiveness of AMS in assessment of cancer risk, screening of drug toxicity and studies of nutrient uptake. In particular, AMS is characterized by measuring xenobiotics at very low dose levels relevant to human environmental exposure. It is sensitive and precise to an attomole (10-18 mole) of 14C per mg carbon. Although it has some shortcomings, undoubtedly, AMS possesses an evident merit of high sensitivity and will have widespread applications in the biomedical sciences.
Introduction
AMS is usually built up based on a tandem Van de Graaff accelerator or other specific accelerator, which consists of ion source, injection system, acceleration facility, high-energy analysis system, detectors and computer controlled system. In general, AMS quantitates long-lived isotopes by counting isotopic nuclei directly through a variety of physical instrumentations.l It provides much greater sensitivity for isotope detection than other decay counting methods, e.g., liquid scintillation counting (LSC). The sensitivity is at attomol of 14C per mg carbon. The detection limit of DNA adducts in AMS measurement reaches 1 adduct/1012 nucleotides.' Besides the very high sensitivity, the merits of AMS also include smaller sample size, lower specific activity and less measuring time allowed in the measurement.
At present, the major application of AMS is in the fields of geoscience, oceanography and archeology based on the chronological evaluation and dating principle. The early pioneering work of bio-AMS (AMS in biomedical sciences) was done by LLNL in 1989.3 They measured adduction of DNA with a food carcinogen McIQx in mouse liver by AMS. In 1994 Liu et al.4 published a review paper on the non-dating applications of AMS, including various biomedical applications. Nowadays, a variety of studies in bio-AMS field have been done and this sophisticated technique has drawn much more attentions in the biomedical community.
The long-lived isotopes can be used in bio-AMS studies are 14c , 3H, 26Al, 36Cl, 41Ca, 99Tc, 1291 etc.. However, the most studies have been carried out with isotope 14C, an isotope of the most essential element in the living organisms. This review paper deals with the studies of carcinogens, pharmaceuticals and nutrients using 14C-AMS.
Carcinogens
The carcinogenesis of a xenobiotic is a function of the dose delivered to an organ, as the dose remains in the tissue inducing the adduction or affinity of the xenobiotic to a key biomolecule. The reaction of chemical xenobiotic with DNA appears to be one of the most important and easily happened events in the initiation phase of cancer. The nature of binding is mainly forming a covalent bond between the small toxicant molecule and the macromolecule. Also there are weak noncovalent bindings, such as groove interaction and electrostatic interaction around DNA helix. Thus, a dose and a time response curve for each organ are required for assessing the cancer risk of organs damaged from a xenobiotic. In the past, the relationship between adduct formation and exposure was primarily established at high dose levels of carcinogen due to the limitation of sensitivity in assay. Bio-AMS may offer a distinct advantage of detecting extremely small amounts of 14C -carcinogen bound to DNA . Table 1 shows 14C-AMS study of carcinogens either to human or animal by researchers of Lawrence Livermore National Lab (LLNL) and their collaborators in U.S. or U.K.. McIQx, a hetrocyclic amine carcinogen found at the ppb level in cooked beef, is the first xenobiotic studied by AMS.3 A linear relationship of DNA-MeIQx adducts and doses over a range of 500 ng/kg b.w. (body weight) to 5 mg/kg b.w. in mouse liver was observed. The 500 ng/kg b.w. dose level; corresponding to 1 adduct/1011 nucleotides, is the lowest dose the authors can statistically discriminate from the control. This is ten to hundred folds improvement over the best sensitivity offered by the 32P-post-labeling assay, and 3 to 5 orders of magnitude better than other techniques used for quantitative assay of DNA adducts. TCD (Dioxin) is an extremely toxic and potent carcinogen. Particularly, in recent years it was recognized as a notorious carcinogenic toxin. In the past, TODD-DNA adducts were not detectable following 6 months of repeated weekly high dose exposure using the most sensitive assay available at that time.5 Because of very high-dose taken in the previous work the extrapolation of the effects to lower relevant exposures was suspected. Compatibly, the present AMS measurement has showed that no TCDD related adducts were found except for very small amounts of adduct observed at the lethal dose level.6 As a very rare exception, these results suggest that the potent carcinogenesis of TCDD is not originated from the effects of initial DNA adduction.
We have measured DNA adduction with one major nitrosa- 
It is a well-known potent and predominant carcinogen and widely present in cigarette smoke as well as unburned tobacco. Its content in cigarettes is roughly 1110,000 of nicotine content. A good linear dependence of DNA-NNK adduct number on the exposure dose levels is shown.' The decay kinetics of DNA-NNK adducts measured shows a slow decay process.8
Carcinogenic Suspects
It is very important to identify whether an organic compound is carcinogenic or not in the cancer toxicological study. In particular, some organic compounds have proven no property of carcinogenesis by conventional medical tests, but they could be genotoxic that indicates they could finally become carcinogenic. AMS has shown a greater potential than the conventional medical methods to solve the identification problem.
3.I. Nicotine. Nicotine, 3-(1-methyl-2-pyrrolidinyl)-pyridine is a major alkaloid in tobacco products, typically comprising 1-2 % weight of tobacco. Nicotine related to smoking is a dominant factor for tobacco addiction. So far it is unclear whether it is carcinogenic to humans.
Since 1994, our group has carried out a series of genotoxicity studies of nicotine in mouse by 14C-AMS.7' 8, 22.24 We found that mouse liver/lung DNA adduction as well as histones(H1 & H3)-nicotine adduction increased with increasing dose level of nicotine, which was equivalent to the level of human exposure to cigarette smoking. Very good linear correlations in the dose response were given. Our findings demonstrate clearly that nicotine damages DNA as well as its closely related significant nucleoprotein histones through the chemical binding in-between. Besides, we have measured the decay kinetics of the adducts and the effect of NaNO2 on liver DNA adduction. By these 14C-AMS studies we have drawn to an important point that nicotine should be no longer only recognized as an addiction factor in smoking, but also a potent carcinogen per se. 14C -AMS has shown the great potential in studies of absorption, distribution, metabolism and excretion (ADME) of pharmaceuticals in human. It is surely recognized by the medical scientists that ADME studies in humans are absolutely indispensable for developing a new drug before it enters the phase of clinical trials in hospital.
Garner et al.29 also have analyzed the pharmacokinetic excretion of drug X (anonymous for the drug company's commercial profit) in human volunteers administered orally 300 nCi of 14C-labelled drug X. Each tablet contained 30 mg of cold drug. This dose was selected as it equated to 0.9 µSv i.e., below the British official regulatory standard. Percentage excreted of drug X in total faeces and urine were measured in terms of mass balances. The authors believe that this kind of early clinical studies by using AMS can shorten largely the drug development times, e.g. 1 yr, thus ensuring that drugs come to market earlier.
We are planning to conduct the ADME studies of the bioactive extracts of some Chinese medicinal herbs using AMS technique. These studies may find access to the discovery of the receptor targets of the extract moleculeees in humans.
Nutrients
Around 1998 Vogel et al.30 created a new application field of AMS studying the distribution and metabolism of nutrients, some vitamins as folic acid and f3-carotene. These studies could be largely extended to a great deal of other common nutritives, which are very important to ensure the healthy life of humans. In the experiments, 100-200 nCi doses of 14C as molecular labels in nutrients were given to the testing volunteers without any radiation damage. In fact, a 70 kg person contains 90 nCi of naturally produced 14C in body. A 100 nCi dose yields at least a 20:1 signal to background level for tracing labelled compounds that may provide satisfactory AMS measurements. 31 Since the 14C-triolein, glycerol tri[1-14C]oleate tests are widely used in the clinical medicine for the determination of fat malabsorption, AMS has been applied in the long-term turnover study of this fatty acid ester in humans at University of Lund, Sweden.32 The measurements were carried out up to 4.5 yr. after administration. 14C contents in exhaled air, fat, muscles, bones, faeces and urine were measured. 60% 14C activity was recovered and the major part of the missing fraction was owing to the uncertainties connected to the large amount of the endogenous production of CO2.
Very recently, AMS was used in an exotic way to distinguish fraudulent synthetics from the naturally products.33 Nowadays, the public consumer trend towards foods and beverages labelled " natural " has created a growing demand. However, in the market so many "natural" foods are blended with inexpensive synthetics. The source of synthetics is mostly petrochemically derived compounds, which contain a low level 14C from the "dead carbon". Through the AMS measurement it is easy to find the fake nutrient blended in the real natural products which originally contains a higher level of 14C equilibrated with the ambient 14C in the natural environment.
